Patents by Inventor Hong-Suk Suh

Hong-Suk Suh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for treatment of osteoporosis
    Patent number: 7662840
    Abstract: This invention relates to a pharmaceutical composition containing 4-[(4-thiazolyl)phenoxyl]alkoxy-benzamidine derivatives expressed by the following formula 1 for the prevention and treatment of osteoporosis and more particularly, to the use of 4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxyl]pentoxy}-benzamidine or N-hydroxy-4-{5-[4-(5-iso-propyl-2-methyl-1,3-thiazol-4-yl)phenoxyl]pentoxy}-benzamidine expressed by the following formula 1, which is known as an antagonist of leukotriene-B4 receptor, as a pharmaceutical composition for the prevention and treatment of osteoporosis. [Formula 1], wherein, R is a hydrogen atom or a hydroxy group.
    Type: Grant
    Filed: March 19, 2002
    Date of Patent: February 16, 2010
    Assignee: Dong Wha Pharmaceutical Co., Ltd.
    Inventors: Hong-Suk Suh, Jin-Soo Lee, Pan-Soo Kim, Yun-Ha Hwang, Jei-Man Ryu, Yong-Ho Chung, Eun-Joo Kim, Do-Hui Kim, Yong-Youp Park
  • Use of 4-[(4-thiazolyl)phenoxy]alkoxy-benzamidine derivatives for treatment of osteoporosis
    Publication number: 20040186150
    Abstract: This invention relates to a pharmaceutical composition containing 4-[(4-thiazolyl)phenoxyl]alkoxy-benzamidine derivatives expressed by the following formula 1 for the prevention and treatment of osteoporosis and more particularly, to the use of 4-{5-[4-(5-isoproply-2-methyl-1,3-thiazol-4-yl)phenoxyl]pentoxy}-benzamidine or N-hydroxy-4-{5-[4-(5-iso-propyl-2-methyl-1,3-thiazol-4-yl) phenoxyl]pentoxy}-benzamidine expressed by the following formula 1, which is known as an antagonist of leukotriene-B4 receptor, as a pharmaceutical composition for the prevention and treatment of osteoporosis. [Formula 1], wherein, R is a hydrogen atom or a hydroxy group.
    Type: Application
    Filed: January 16, 2004
    Publication date: September 23, 2004
    Inventors: Hong-Suk Suh, Jin-Soo Lee, Pan-Soo Kim, Yun-Ha Hwang, Jei-Man Ryu, Yong-Ho Chung, Eun-Joo Kim, Do-Hui Kim, Yong-Youp Park
  • 3-amino-1,2-benzoisoxazole derivatives, process for preparation, and use thereof
    Patent number: 6150390
    Abstract: The present invention relates to a novel 3-amino-1,2-benzoisoxazole derivatives, represented by Formula I, LTB-4[leukotriene-B-4; 5(S),12(R)-dihydroxy-6,14-cis-8,10-trans-eicosatetraenoic acid] receptor antagonist, process for preparation thereof, and use thereof for LTB-4 receptor antagonist or therapeutics for osteoporosis. ##STR1## (in which n is integer of 3-5).
    Type: Grant
    Filed: July 21, 1999
    Date of Patent: November 21, 2000
    Assignee: Dong Wha Pharm. Ind. Co., Ltd.
    Inventors: Hong-Suk Suh, Jae-Ha Ryu, Yong-Nam Han, Sung-June Yoon, Jong-Woo Kim